There are plenty of laser technologies for the practice, but then there are cornerstone lasers every practice should have. Learn more in this article from the Fall Clinical conference.
While botulinum toxin is most commonly used to relieve frowns and wrinkles, it is increasingly being shown to be associated with improving mood and relationships, a researcher says.
Approximately 40% of acne patients have scars — and scarring can occur in any severity of acne. Watch this video to hear Drs. Hilary Baldwin and Linda Stein Gold describe how a decrease in acne lesions can lead to a decrease in scars, even in moderate to severe acne patients. Also watch Dr. Joshua Zeichner discuss his approach to the treatment of acne for teens and young adults.
Topical 5-fluorouracil (5-FU), which is FDA approved for treating actinic keratoses and superficial basal cell carcinoma, shows the strongest evidence of effectiveness for these two conditions plus squamous cell carcinoma, according to a comprehensive systematic review.
Study finds daylight photodynamic therapy with ablative fractional laser more effective than with microdermabrasion for treating actinic keratoses with large area field cancerization.
Reporting from Fall Clinical in Las Vegas, Dr. James Del Rosso reviews best practices for topical therapy uses in psoriasis and atopic dermatitis.
A minimally-invasive surgical skin contouring procedure, currently under investigation, could give patients a new option for removing fat and tightening skin, according to recent clinical trial findings.
A single treatment for cellulite, which affects 85 percent of women, can reduce the appearance of fat on patients’ buttocks and thighs for five years, according to results of a multi-year effectiveness study.
Increasingly higher doses of incobotulinumtoxinA (Xeomin) offer patients a longer duration of response in the treatment for glabellar frown lines, according to recently-presented clinical trial results.
Superficial radiation therapy (SRT) targets only skin cancer cells and has few side effects, researchers reported at the American Society for Dematologic Surgery annual meeting.